Amano Katsushi, Leung Patrick S C, Rieger Roman, Quan Chao, Wang Xiaobing, Marik Jan, Suen Yat Fan, Kurth Mark J, Nantz Michael H, Ansari Aftab A, Lam Kit S, Zeniya Mikio, Matsuura Eiji, Coppel Ross L, Gershwin M Eric
Division of Rheumatology, Allergy and Clinical Immunology, Genomic and Biomedical Sciences Facility, University of California, Davis, CA 95616, USA.
J Immunol. 2005 May 1;174(9):5874-83. doi: 10.4049/jimmunol.174.9.5874.
Emerging evidence has suggested environmental factors as causative agents in the pathogenesis of primary biliary cirrhosis (PBC). We have hypothesized that in PBC the lipoyl domain of the immunodominant E2 component of pyruvate dehydrogenase (PDC-E2) is replaced by a chemical xenobiotic mimic, which is sufficient to break self-tolerance. To address this hypothesis, based upon our quantitative structure-activity relationship data, a total of 107 potential xenobiotic mimics were coupled to the lysine residue of the immunodominant 15 amino acid peptide of the PDC-E2 inner lipoyl domain and spotted on microarray slides. Sera from patients with PBC (n = 47), primary sclerosing cholangitis (n = 15), and healthy volunteers (n = 20) were assayed for Ig reactivity. PBC sera were subsequently absorbed with native lipoylated PDC-E2 peptide or a xenobiotically modified PDC-E2 peptide, and the remaining reactivity analyzed. Of the 107 xenobiotics, 33 had a significantly higher IgG reactivity against PBC sera compared with control sera. In addition, 9 of those 33 compounds were more reactive than the native lipoylated peptide. Following absorption, 8 of the 9 compounds demonstrated cross-reactivity with lipoic acid. One compound, 2-octynoic acid, was unique in both its quantitative structure-activity relationship analysis and reactivity. PBC patient sera demonstrated high Ig reactivity against 2-octynoic acid-PDC-E2 peptide. Not only does 2-octynoic acid have the potential to modify PDC-E2 in vivo but importantly it was/is widely used in the environment including perfumes, lipstick, and many common food flavorings.
新出现的证据表明,环境因素是原发性胆汁性肝硬化(PBC)发病机制中的致病因素。我们推测,在PBC中,丙酮酸脱氢酶(PDC-E2)免疫显性E2成分的硫辛酰结构域被一种化学异生素模拟物取代,这足以打破自身耐受性。为了验证这一假设,基于我们的定量构效关系数据,总共107种潜在的异生素模拟物与PDC-E2内部硫辛酰结构域免疫显性15氨基酸肽的赖氨酸残基偶联,并点样在微阵列载玻片上。检测了PBC患者(n = 47)、原发性硬化性胆管炎患者(n = 15)和健康志愿者(n = 20)血清中的Ig反应性。随后,用天然硫辛酰化的PDC-E2肽或异生素修饰的PDC-E2肽吸收PBC血清,并分析剩余的反应性。在这107种异生素中,33种与对照血清相比,对PBC血清的IgG反应性显著更高。此外,这33种化合物中有9种比天然硫辛酰化肽的反应性更强。吸收后,这9种化合物中有8种与硫辛酸表现出交叉反应性。一种化合物,2-辛炔酸,在其定量构效关系分析和反应性方面都很独特。PBC患者血清对2-辛炔酸-PDC-E2肽表现出高Ig反应性。2-辛炔酸不仅有可能在体内修饰PDC-E2,而且重要的是,它过去/现在广泛应用于环境中,包括香水、口红和许多常见的食品调味剂。